β2-Adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern

American Journal of Clinical Nutrition

Volumn 92, Issue 2, 2010, Pages 444-449

  Sun, Bei ^a   Williams, Jonathan S ^a   Svetkey, Laura P ^b   Kolatkar, Nikheel S ^c,d   Conlin, Paul R ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BETA 2 ADRENERGIC RECEPTOR; POTASSIUM; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DNA POLYMORPHISM; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POTASSIUM URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; ALLELE; BLOOD; BLOOD PRESSURE; CONTROLLED CLINICAL TRIAL; DIET; GENETICS; GENOTYPE; MIDDLE AGED; NUTRIGENOMICS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; URINE;

ALDOSTERONE; ALLELES; BLOOD PRESSURE; DIET; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NUTRIGENOMICS; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM; RECEPTORS, ADRENERGIC, BETA-2; REGRESSION ANALYSIS; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 77955507703     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28924     Document Type: Article

References (29)

1. Svetkey LP, Chen YT, McKeown SP, Preis L, Wilson AF. Preliminary evidence of linkage of salt sensitivity in black Americans at the beta 2-adrenergic receptor locus. Hypertension 1997;29:918-22. (Pubitemid 27152459)
2. Caulfield M, Munroe P, Pembroke J, et al. Genome-wide mapping of human loci for essential hypertension. Lancet 2003;361:2118-23.
3. Insel PA. Seminars in medicine of the Beth Israel Hospital, Boston. Adrenergic receptors-evolving concepts and clinical implications. N Engl J Med 1996;334:580-5.
4. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJ. Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: correlation with beta-receptor function in vitro. Clin Pharmacol Ther 1990;48:87-95. (Pubitemid 20236206)
5. Stein CM, Nelson R, Deegan R, He H, Wood M, Wood AJ. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995;96:579-85.
6. Lang CC, Stein CM, Brown RM, et al. Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med 1995;333:155-60.
7. Kopp UCDG. Interaction between epinephrine and renal nerves in control of renin secretion rate. Am J Physiol 1986;250:F999-1007.
8. DiBona GF. Neural control of the kidney: functionally specific renal sympathetic nerve fibers. Am J Physiol Regul Integr Comp Physiol 2000;279:R1517-24.
9. Kim SMCL, Faulhaber-Walter R, Oppermann M, et al. Regulation of renin secretion and expression in mice deficient in beta1- and beta2-adrenergic receptors. Hypertension 2007;50:103-9.
10. Dishy V, Sofowora GG, Xie HG, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030-5.
11. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9.
12. Timmermann B, Mo R, Luft FC, et al. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 1998;53:1455-60.
13. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 2005;294:1526-33. (Pubitemid 41362690)
14. Pojoga L, Kolatkar NS, Williams JS, et al. Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension 2006;48:892-900.
15. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336:1117-24.
16. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10.
17. Conlin PR, Erlinger TP, Bohannon A, et al. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Am J Hypertens 2003;16:337-42.
18. Akita S, Sacks FM, Svetkey LP, Conlin PR, Kimura G. Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship. Hypertension 2003;42:8-13.
19. Emanuel RL, Cain JP, Williams GH. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 1973;81:632-40.
20. Svetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999;159:285-93.
21. Bao X, Mills PJ, Rana BK, et al. Interactive effects of common beta2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function. Hypertension 2005;46:301-7. (Pubitemid 41099161)
22. Conlin PR, Chow D, Miller ER 3rd, et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens 2000;13:949-55.
23. Svetkey LP, Moore TJ, Simons-Morton DG, et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001;19:1949-56.
24. Bray MS, Krushkal J, Li L, et al. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000;101:2877-82.
25. Krushkal J, Xiong M, Ferrell R, Sing CF, Turner ST, Boerwinkle E. Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 1998;7:1379-83.
26. Tomaszewski M, Brain NJ, Charchar FJ, et al. Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis. Hypertension 2002;40:286-91.
27. Cockcroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, Noon JP. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000;36:371-5.
28. Garovic VD, Joyner MJ, Dietz NM, Boerwinkle E, Turner ST. Beta (2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 2003;546:583-9.
29. Eisenach JH, Schroeder DR, Pike TL, et al. Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans. J Physiol 2006;574:955-65.